View Item 

Show simple item record

A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads
dc.contributor.authorJones, M. P.en_US
dc.contributor.authorChey, W. D.en_US
dc.contributor.authorSingh, S.en_US
dc.contributor.authorGong, H.en_US
dc.contributor.authorShringarpure, R.en_US
dc.contributor.authorHoe, N.en_US
dc.contributor.authorChuang, E.en_US
dc.contributor.authorTalley, N. J.en_US
dc.date.accessioned2014-02-11T17:56:55Z
dc.date.available2015-04-01T19:59:06Zen_US
dc.date.issued2014-02en_US
dc.identifier.citationJones, M. P.; Chey, W. D.; Singh, S.; Gong, H.; Shringarpure, R.; Hoe, N.; Chuang, E.; Talley, N. J. (2014). "A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads." Alimentary Pharmacology & Therapeutics 39(4): 426-437.en_US
dc.identifier.issn0269-2813en_US
dc.identifier.issn1365-2036en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/102638
dc.publisherWiley Periodicals, Inc.en_US
dc.titleA biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leadsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbsecondlevelOtolaryngologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/102638/1/apt12608.pdf
dc.identifier.doi10.1111/apt.12608en_US
dc.identifier.sourceAlimentary Pharmacology & Therapeuticsen_US
dc.identifier.citedreferenceLembo A, Neri B, Tolley J, et al. Use of serum biomarkers in a diagnostic test for irritable bowel syndrome. Aliment Pharmacol Ther 2009; 29: 834 – 42.en_US
dc.identifier.citedreferenceAerssens J, Camilleri M, Talloen W, et al. Alterations in mucosal immunity identified in the Colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008; 6: 194 – 205.en_US
dc.identifier.citedreferenceHarris C, Ma T, Leighton J, et al. Novel genomic biomarkers that differentiate between irritable bowel syndrome and normal patients using peripheral blood specimens. Am J Gastroenterol 2008; 103: S468.en_US
dc.identifier.citedreferenceTalley N, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002; 360: 555 – 64.en_US
dc.identifier.citedreferenceWalker E, Roy‐Byrne P, Katon W. Irritable bowel syndrome and psychiatric illness. Am J Psychiatry 1990; 147: 565 – 72.en_US
dc.identifier.citedreferenceGros D, Antony M, McCabe R, et al. Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression. J Anxiety Disord 2009; 23: 290 – 6.en_US
dc.identifier.citedreferenceDrossman D. Do psychosocial factors define symptom severity and patient status in irritable bowel syndrome? Am J Med 1999; 107 ( suppl ): 41 – 50.en_US
dc.identifier.citedreferenceDitto B, Miller S, Barr R. A one‐hour active coping stressor reduces small bowel transit time in healthy young adults. Psychosom Med 1998; 60: 7 – 10.en_US
dc.identifier.citedreferenceFossey M, Lydiard R. Anxiety and the gastrointestinal system. Psychiatr Med 1990; 8: 175 – 86.en_US
dc.identifier.citedreferenceDrossman D. Gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998; 60: 258 – 67.en_US
dc.identifier.citedreferenceWhitehead W, Palsson O, Levy R, et al. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007; 102: 2767 – 76.en_US
dc.identifier.citedreferenceFrancis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395 – 402.en_US
dc.identifier.citedreferenceDrossman DA, Li Z, Toner BB, et al. Functional bowel disorders: a multicenter comparison of health status and development of illness severity index. Dig Dis Sci 1995; 40: 986 – 95.en_US
dc.identifier.citedreferenceZigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361 – 70.en_US
dc.identifier.citedreferenceKroenke K, Spitzer R, Williams J. The PHQ‐15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002; 64: 258 – 66.en_US
dc.identifier.citedreferenceBenjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995; 57: 289 – 300.en_US
dc.identifier.citedreferenceVivinus‐Nébot M, Dainese R, Anty R, et al. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol 2012; 107: 75 – 81.en_US
dc.identifier.citedreferenceWalker M, Warwick A, Ung C, et al. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep 2011; 13: 323 – 30.en_US
dc.identifier.citedreferenceFord A, Talley N. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol 2011; 46: 421 – 31.en_US
dc.identifier.citedreferenceFord A, Talley N. IBS in 2010: advances in pathophysiology, diagnosis and treatment. Nat Rev Gastroenterol Hepatol 2011; 8: 76 – 8.en_US
dc.identifier.citedreferenceBossuyt P, Reitsma J, Bruns D, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003; 138: W1 – 12.en_US
dc.identifier.citedreferenceCremonini F, Talley N. Irritable bowel syndrome: epidemiology, natural history, health‐care seeking and emerging risk factors. Gastroenterol Clin North Am 2005; 34: 189 – 204.en_US
dc.identifier.citedreferenceThompson W, Longstreth G, Drossman D, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 ( Suppl 2 ): II43 – 7.en_US
dc.identifier.citedreferenceBrandt L, Chey W, Foxx‐Orenstein A, et al. An evidence‐based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 ( Suppl 1 ): S1 – 35.en_US
dc.identifier.citedreferenceChey W, Nojkov B, Rubenstein J, et al. The yield of colonoscopy in patients with non‐constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010; 105: 859 – 65.en_US
dc.identifier.citedreferenceSpiegel B, Farid M, Esrailian E, et al. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010; 105: 848 – 58.en_US
dc.identifier.citedreferenceLacy B, Rosemore J, Robertson D, et al. Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome. Scand J Gastroenterol 2006; 41: 892 – 902.en_US
dc.identifier.citedreferenceCash B, Schoenfeld P, Chey W. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97: 2812 – 9.en_US
dc.identifier.citedreferenceSchmulson M, Chang L. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999; 107 ( 5A ): 20S – 6S.en_US
dc.identifier.citedreferenceTillisch K & Chang L Diagnosis and treatment of irritable bowel syndrome: state of the art. Curr Gastroenterol Rep 2005; 7: 249 – 56.en_US
dc.identifier.citedreferenceGershon M. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol 2005; 39 ( 5, Suppl 3 ): S184 – 93.en_US
dc.identifier.citedreferenceCoates M, Mahoney C, Linden D, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126: 1657 – 64.en_US
dc.identifier.citedreferenceMawe G, Coates M, Moses P. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther 2006; 23: 1067 – 76.en_US
dc.identifier.citedreferenceRóka R, Rosztóczy A, Leveque M, et al. A pilot study of fecal serine‐protease activity: a pathophysiologic factor in diarrhea‐predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007; 5: 550 – 5.en_US
dc.identifier.citedreferenceBarbara G, Wang B, Stanghellini V, et al. Mast cell‐dependent excitation of visceral‐nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26 – 37.en_US
dc.identifier.citedreferenceGuilarte M, Santos J, Torres Id, et al. Diarrhoea‐predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203 – 9.en_US
dc.identifier.citedreferenceBarbara G, Stanghellini V, Giorgio Rd, et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693 – 702.en_US
dc.identifier.citedreferenceO'Sullivan M, Clayton N, Breslin N, et al. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000; 12: 449 – 57.en_US
dc.identifier.citedreferenceFeng B, La JH, Schwartz ES, Gebhart GF. Neural and neuro‐immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012; 8: 2012.en_US
dc.identifier.citedreferenceSpiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979 – 88.en_US
dc.identifier.citedreferenceVidelock EJ, Adeyemo M, Licudine A, et al. Childhood trauma is associated with hypothalamic‐pituitary‐adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 2009; 137: 1954 – 62.en_US
dc.identifier.citedreferenceLiebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913 – 20.en_US
dc.identifier.citedreferenceTalley NJ, Fodor AA. Bugs, stool, and the irritable bowel syndrome: too much is as bad as too little? Gastroenterology 2011; 141: 1555 – 9.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
apt12608.pdf
Size:
270.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.